Research is at the heart of advances in treatment and care for Duchenne muscular dystrophy and funding Duchenne research is a core objective for Parent Project Muscular Dystrophy (PPMD). PPMD’s research programs, which run the gamut from small bridge grants to seven figure awards for drug development, are all designed to fund projects directly aimed at the development of new therapies for Duchenne.
Applications to PPMD are reviewed by either:
2016 Funding Opportunities
Our 2016 research budget has been allocated and we are accepting no new proposals to review in 2016. We will be evaluating our research strategy and budget in early 2017 and will announce our plans then.
- Exploratory Awards
PPMD has developed the PPMD Exploratory Award for the development of preliminary data for new ideas or studies that are highly relevant to Duchenne muscular dystrophy therapy development. View the Exploratory Funds page for more information. We will announce in early 2017 any RFA’s for Exploratory Awards we are planning.
- Investigator Award
PPMD has developed the PPMD Investigator Award to fund meritorious studies in academic laboratories directly related to the development of new therapies for Duchenne muscular dystrophy. View the investigator award page for more information. We will announce in early 2017 any RFA’s for Investigator Awards we are planning.
Other Funding Opportunities
Rapid and open sharing of new research data, analyses, and ideas. PLoS Currents: Muscular Dystrophy enables research results and ideas to be shared immediately while ensuring that they will be permanently archived and citable. PLoS Currents provides open access to all content, ensuring that authors reach the widest possible audience. All content is reviewed by a group of expert researchers. PPMD is proud to provide support to launch and maintain PLoS Currents: Muscular Dystrophy.
In this section
Apply for Funding